Search Videos and More
Showing 1 - 8 of 8 results
News
HER2-Targeted Agents: Not Just for Breast Cancer
With 20% of breast cancers driven by alterations to the HER2 gene, inhibiting the expression of this gene has been an objective of researchers and clinicians for decades, and a number of inhibitory therapies have been developed.
News
A New Fellowship For Breast Imaging Leadership
The new fellow will spend nine months on interpreting, screening, and diagnostic procedures, learn how to perform all forms of biopsies using the most advanced techniques; and gain skills to run a breast imaging center.
News
Fox Chase Researchers Present Findings on BRCA-Mutated Breast Cancer at American Society for Radiation Oncology Meeting
Video
Breast Cancer Screening Guidelines: What You Should Know
Watch this short video on the three components of breast cancer screening—brought to you by Andrea Porpiglia, MD, MSc, FACS, Assistant Professor, Department of Surgical Oncology at Fox Chase.
News
Adjuvant Olaparib a Win for High-Risk, BRCA-Mutant Early Breast Cancer
Researchers at Fox Chase Cancer Center discuss the benefits of the PARP inhibitor olaparib for women with high-risk, HER2-negative, BRCA-mutant early breast cancer.
Symposium
19th Annual San Antonio Breast Cancer Symposium
Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education, this virtual CME is designed to help medical, radiation and surgical oncologists, gynecologists, radiologists, and primary care physicians translate the data from key presentations from the 2020 San Antonio Breast Cancer Symposium into practice.
News
Fox Chase Becomes First Cancer Center in the Northeast to Utilize New Surgical Navigation Technology for Breast-Conserving Surgeries
Fox Chase Cancer Center is the first cancer center in the Northeast to feature a new tumor marker technology—the EnVisio Surgical Navigation System and SmartClip Soft Tissue Marker technology. This advancement will make breast excisional biopsies and breast-conserving surgeries more precise.
News
Fox Chase Researchers Actively Recruiting for Breast Cancer Immunotherapy Trials
Recognizing the need for further evaluation of immunotherapy for breast cancer treatment, Fox Chase Cancer Center has opened two investigator-initiated trials exploring the use of immunotherapy for triple-negative and HER2-positive breast cancer.